+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve



In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve



Pathologie-Biologie 39(5): 367-373



Minimal inhibitory concentrations (MICs) of piperacillin (P) in combination with 4 micrograms/ml of tazobactam (T) were evaluated by agar dilution for 1,245 strains isolated in 4 hospitals. In addition antibiograms by agar diffusion were performed with disks loaded of 75 micrograms of P + 10 micrograms of T. For naturally non beta-lactamase producing Enterobacteriaceae (E), MIC 50 and 90% of P + T were (microgram/ml): E. coli 1-2; P. mirabilis: 0.5-1; activity was practically identical on plasmid mediated penicillinase (Pase) producing strains. Strains of K. pneumoniae only resistant (R) to amino- and carboxypenicillins (C) had MICs less than or equal to 4 (mode MIC 2); MICs of strains R to cephalothin and/or cefotaxime were 2 to 16 (mode MIC 4). For chromosomal cephalosporinase (Case) producing species, MICs of P + T were less than or equal to 8, including for acquired Pase producing strains, but were greater than or equal to 16 for Case hyperproducing strains. Strains of P. aeruginosa susceptible (S) to C were inhibited by 1 to 16 (with MIC 4) and strains R to C by 8 to greater than 128. MICs were generally 2 to 32 for A. baumannii S to C at 0.12 to greater than 128 for strains R to C. Haemophilus, S or R to ampicillin, were inhibited by 0.008 to 2 (MIC 50 and 90: 0.016-0.12). S. aureus S to methicillin (M), Pase producing on not, were inhibited by 0.5 to 2 (mode MIC 1) and strains R to M by 8 to greater than 128. Activity of P + T for coagulase-Staphylococci was similar.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040389021

Download citation: RISBibTeXText

PMID: 1652727


Related references

In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin. Pathologie-Biologie 43(3): 208-214, 1995

Antibacterial in vitro activity of piperacillin-tazobactam in combination with netilmicin or amikacin against amoxicillin-resistant strains of Enterobacteriaceae. Pathologie Biologie 43(3): 208-214, 1995

Evaluation of in vitro susceptibility of hospital bacterial isolates to piperacillin and tazocin (piperacillin/tazobactam. Medycyna Doswiadczalna i Mikrobiologia 50(1-2): 41-46, 1998

Inhibition of -lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin. Journal of Antimicrobial Chemotherapy 25(4): 567-574, 1990

Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin. Journal of Antimicrobial ChemoTherapy 25(4): 567-574, 1990

Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates. Journal of ChemoTherapy 2(5): 295-299, 1990

Antibacterial activity of piperacillin and tazobactam against beta-lactamase-producing clinical isolates. ChemoTherapy 36(5): 356-364, 1990

Antibacterial activity of tazocin (piperacillin/tazobactam) against 1296 clinical isolates from a tertiary care center. Annals of Saudi Medicine 16(4): 377-380, 1996

A national multicenter study of the in-vitro activity of piperacillin-tazobactam. The Spanish Piperacillin-Tazobactam Group. Revista Espanola de Quimioterapia 11(2): 139-146, 1998

Comparative antibacterial activities of meropenem , imipenem , ceftazidime , piperacillin/tazobactam , ciprofloxacin and tobramycin , singly and in combination against resistant and susceptible isolates of Pseudomonas aeruginosa. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 104, 1995

Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses. Antimicrobial Agents and ChemoTherapy 48(5): 1688-1698, 2004

In vitro antibacterial activity of a new fluoroquinolone, enoxacin against hospital bacteria and regression curve. Pathologie-Biologie 43(4): 274-280, 1995

In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve. Pathologie-Biologie 42(5): 385-392, 1994

In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species. Antimicrobial Agents and ChemoTherapy 38(2): 200-204, 1994

Synergistic effect of polyethylenimine plus piperacillin/tazobactam on clinical Pseudomonas aeruginosa isolates resistant to piperacillin/tazobactam. Annals of Microbiology 56(4): 345-348, 2006